HEPATOLOGY, July 1998, p. 45-49, Vol. 28, No. 1
Original Articles
Subclinical Hepatic Encephalopathy Impairs Daily
Functioning
Michael Groeneweg1, Juan C. Quero1, Ilone De
Bruijn1, Ieneke J. C. Hartmann1, Marie-louise
Essink-bot2, Wim C. J. Hop3, and Solko W.
Schalm1
From the Departments of 1
Hepatogastroenterology, 2 Public Health, and
3 Biostatistics, Erasmus University Hospital, Dr.
Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
ABSTRACT
Subclinical hepatic encephalopathy (SHE) is assumed to have a
negative effect on patients' daily functioning; therefore,
treatment is recommended. However, no studies have been performed
that document the clinical relevance of SHE. We performed a study
in which the prevalence of SHE was determined in 179 outpatients
with cirrhosis using two psychometric tests (Number Connection Test
Part A [NCT-A] and the Digit Symbol Test [DGT]) and automated
analysis of the electroencephalogram (EEG). SHE was defined by the
presence of at least one abnormal psychometric test and/or abnormal
slowing of the EEG. The influence of cirrhosis and SHE on patients'
daily functioning was assessed using the Sickness Impact Profile
(SIP) questionnaire. The distribution of SIP scores of the patients
with cirrhosis differed from the reference scores of the general
population. Patients with cirrhosis and SHE (n = 48) reported
significantly more impairment in all 12 scales of the SIP, in the
psychosocial subscore, the physical subscore, as well as in the
total SIP score, compared with cirrhotic patients without SHE (n =
131). Multivariate analysis taking into account severity of liver
disease (Child-Pugh score), presence of varices, and alcoholic
etiology, showed that SHE independently was related to a diminished
total SIP score. The reproducibility of the SIP was high when the
test was repeated after a 3-month period. We conclude that SHE
implies impaired daily functioning and warrants attempts at
treatment. (HEPATOLOGY 1998;28:45-49.)
INTRODUCTION
Clinical manifestations of hepatic encephalopathy include a
decreased intellectual function, personality disorders, an altered
level of consciousness, and neuromuscular dysfunction.1
In addition to clinical manifest hepatic
encephalopathy,2 a subclinical stage has been described,
which cannot be detected through global clinical examination, but
requires specific neuropsychological and neurophysiological
examination.3-12 The prevalence of subclinical hepatic
encephalopathy (SHE) is estimated to vary from 30% to 84% according
to recent studies using appropriate methods.12-16 This
variation in reported prevalence depends on the kind (psychometric
or electrophysiological) and number of tests used, and the
population (etiology and severity of the liver disease)
tested.17
SHE is considered to be clinically relevant for two reasons.
First, it could be a preceding stage of clinical manifest hepatic
encephalopathy.3 However, this assumption is not proven,
because only one follow-up study16 supports this
concept. Second, the psychomotor deficits found in SHE could have a
disadvanting influence on patients' daily functioning, e.g.,
driving a car or performing at work.18 In view of the
reported high prevalence of SHE and its presumed negative effect on
daily life, routine screening of cirrhotic patients for SHE and
treatment of SHE is recommended.19-21 However, the need
of treatment of SHE is questionable, because a recent study has
shown that patients with SHE did not perform worse driving "on the
road" than patients without SHE.22 Driving a car is an
important, but small, part of the total spectrum of daily
activities. Therefore, on the basis of this study, no conclusions
can be made about the effect of SHE on other aspects of daily
functioning.
The influence of chronic diseases on daily life can be assessed
using "Health-related Quality of Life" questionnaires.23
The "Sickness Impact Profile" (SIP) questionnaire24,25
is such an instrument for overall health assessment and has been
used before to determine the influence of chronic liver disease on
patients' daily functioning.26-29
The aim of the present study was to determine the prevalence of
neuropsychological and neurophysiological defects in stable
cirrhotic patients attending a university hospital outpatient
clinic using two neuropsychological tests and the
neurophysiological method of automated analysis of the
electroencephalogram (EEG). The SIP questionnaire was used to
determine the influence of SHE on daily functioning. In addition,
the reproducibility of the SIP in cirrhotic patients was
determined.
PATIENTS AND METHODS
Subjects and Investigations
From January 1, 1992, to May 1, 1996, 202 consecutive patients
attending the outpatient clinic of Hepatogastroenterology of the
University Hospital Rotterdam were screened for SHE. Inclusion
criteria were: histologically proven cirrhosis and age between 16
and 80 years. One hundred ninety-three of 202 patients fitted the
inclusion criteria; 3 patients had a surgically constructed
portacaval shunt (no cirrhosis), and 6 patients only had clinical
signs of cirrhosis at screening. Exclusion criteria were: clinical
manifest hepatic encephalopathy*; history of recent (less than 6
weeks) alcohol abuse; use of benzodiazepines, anti-epileptics, or
other psychotropic drugs; inability to perform the psychometric
tests and to complete the SIP questionnaire (caused by either
insufficient knowledge of the Dutch language or bad vision); and
severe medical problems such as congestive heart failure, pulmonary
disease, neurological disease, etc., that influence the
quality-of-life measurement.
In the final analysis, a total of 179 patients with
histologically proven cirrhosis were included. Fourteen patients
were excluded because of incomplete SHE screening and/or inability
to fill out the quality-of-life questionnaire.
All patients underwent a clinical and laboratory investigation,
psychometric tests, and automated EEG analysis. In addition, the
SIP questionnaire was administered. All examinations took place on
the same day. Test-retest reliability of the SIP was assessed by
re-administering the questionnaire to patients without signs of
decompensated liver disease (i.e., jaundice, ascites,
encephalopathy, or variceal bleeding) after a 3-month period.
Clinical and Laboratory Assessment
The Child-Pugh score was used to assess the severity of liver
disease.31 Three biochemical variables (serum albumin,
bilirubin, and prothrombin time) in addition to the two clinical
characteristics (presence or absence of ascites and clinical signs
of encephalopathy) determine the Child-Pugh score. Each variable is
given 1 to 3 points, leading to scores ranging from 5 (excellent
liver function) to 15 points (poor liver function).
Presence of esophageal or gastric varices was evaluated, using
reports of endoscopic investigations in 174 patients, and
esophageal x-rays in 5 patients.
Alcoholic etiology of cirrhosis was defined as: presence of
severe alcohol abuse in patient history and absence of other
etiological factors.
Neuropsychological Assessment
Number Connection Test Part A. This test is a derivative
from the Trail Making Test32 and measures cognitive
motor abilities. In the Number Connection Test Part A (NCT-A),
patients must connect numbers printed on paper consecutively from 1
to 25. Age-related normal values of this NCT-A have been developed
in 681 persons without liver disease.33 Normal values
are expressed as the mean ± 2 SD. After explanation,
abbreviated demonstration tests were administered to be sure the
patient had understood it. Errors were not enumerated, but patients
were instructed to return to the preceding correct number and then
carry on. The test score is the time the patient needs to perform
the test, including the time needed to correct the errors. A low
score indicates a good performance.
Digit Symbol Test. This is a subtest of the Wechsler
Adult Intelligence Scale and measures motor speed and
accuracy.34 The patient is given a list of digits from 1
to 9 associated with symbols and is asked to fill in blanks with
symbols that correspond to each number. The test score is the total
number of correct sequential matchings of symbols to numbers in a
90-second interval. The normative data used are expressed as
percentiles. After explanation of each test, an abbreviated
demonstration was administered to ensure that the patient
understood the test correctly. A high score indicates a good
performance. Data of 2,169 Dutch and Belgian healthy controls
served as a reference group in the Netherlands.35 A test
result below the 2.5th percentile (i.e., the mean 2 SD) is considered
abnormal.
Neurophysiological Assessment
The EEG was recorded using standardized techniques while the
patient, with the eyes closed, laid comfortably in a quiet room.
When drowsiness occurred, an auditory stimulus was applied by the
EEG technician. Five electrodes were attached to the skin at the
positions T3, T4, O1, O2, and Cz according to the international
"10-20 system."36 Electrode impedance was kept lower
than 5 k . After applying
the usual band-pass filters (0.53-35 Hz), two runs of 100 seconds
each were recorded and compared for reproducibility. Artefact-free
recordings were selected and fed into a computer after
analogue-digital conversion (sample frequency, 102.4 Hz). Ten
epochs of 10 seconds each were analyzed by applying Fast Fourier
Transformation and the mean power spectrum calculated. Patients are
graded in the different stages of hepatic encephalopathy on account
of their mean dominant frequency, and the relative powers of delta
and theta activity. In a previous study,37 we have
validated this method in 51 healthy controls (median age, 41 years;
range, 21-78 years) and 66 patients with cirrhosis (median age, 60
years; range, 21-75 years). A theta activity above 35% (i.e., the
mean + 2 SD in controls) is considered abnormal.
Assessment of Daily Functioning
The SIP questionnaire is an often-used instrument that assesses
the influence of disease and treatment on daily
functioning.24 The questionnaire consists of 136 items,
which are grouped into 12 scales: sleep and rest, eating, work,
home management, recreation and pastimes, ambulation, mobility,
body care and movement (scores of the latter three may be combined
as a physical subscore), social interaction, alertness behavior,
emotional behavior, and communication (scores of the latter four
may be combined as a psychosocial subscore). Apart from a
12-dimensional profile score and the physical and psychosocial
scores, the SIP provides the opportunity to compute a total score.
Each score ranges from 0 (best score) to 100 (worst score).
Patients mark only items that relate to their health at that time.
The SIP has been translated and validated for the Dutch
population.38,39
Statistical Analysis
Fisher's Exact test was used to assess differences in sex
(male:female), age-group (<60 years: 60 years), Child-Pugh score (A:B/C), etiology of
cirrhosis (alcohol:other), and presence of varices between patients
with and without SHE. Difference in median age was tested, using
the Wilcoxon rank sum test. Those variables reaching (borderline)
statistical significance in the univariate analysis were selected
for multivariate analysis, using multiple regression to determine
their influence on total SIP score. In this analysis, total SIP
scores were logarithmically transformed to reduce skewness of
distributions. The limit for statistical significance was set at
P = .05. Test-retest reliability (reproducibility) was
assessed using intraclass correlation coefficients. Values above
0.7 generally are considered to indicate good
reliability.40 Internal consistency reliability of the
SIP scales was assessed using Cronbach's .41 The
internal consistency of a multi-item scale is a measure of the
homogeneity of the items. An of 0.70 is considered to demonstrate
good internal consistency.42
RESULTS
One hundred seventy-nine patients with histologically proven
cirrhosis (113 male, 66 female; mean age, 50 years; SD 14; range,
18-77 years) entered the final analysis. The etiology of cirrhosis
was chronic viral hepatitis in 71 patients, alcohol abuse in 38
patients, and other causes (e.g., autoimmune, primary biliary
cirrhosis, cryptogenic) in 70 patients. None of the patients had
evidence of neurological and/or psychiatric abnormalities on global
clinical examination performed in each patient by one of the first
two authors (M.G. and J.C.Q.).
table 1
summarizes the prevalence of abnormality in age-related
psychometric tests and automated EEG analysis found in the study
population. Forty-eight patients had slowing of the EEG (at least
grade 1 by spectral analysis) and/or at least one abnormal
psychometric test. These 48 patients were considered as having SHE,
while the remaining 131 patients were considered not to have
SHE.15 Clinical and laboratory characteristics of both
patient groups are summarized in table 2. The
male/female ratio did not differ between groups. Patients with SHE
had a more severe liver disease, as quantified by the Child-Pugh
score, and more often had esophageal or gastric varices. Moreover,
patients with SHE more often had alcoholic etiology of cirrhosis
and they tended to be older: 55 (36-74) years versus 50 (18-77)
(median age [range]) years for cirrhotic patients without SHE.
However, no difference was found in the number of patients older
than 60 years of age (table 2).
|
View This
table
|
table 1. Prevalence of Abnormal Neuropsychological and
Neurophysiological Tests and the Diagnosis of SHE in 179 Cirrhotic
Patients Without Clinical Signs of Hepatic Encephalopathy |
| View This
table |
table 2. Clinical and Laboratory Characteristics of
Cirrhotic Patients With and Without SHE |
Figure 1 shows that the mean SIP
scores of patients with and without SHE compared with reference
scores of the general population.39 Patients with
cirrhosis and SHE reported significantly more impairment in all 12
scales of the SIP, in the psychosocial subscore, the physical
subscore, as well as in the total SIP score, compared with
cirrhotic patients without SHE (table 3).
| Fig. 1. Mean SIP scale
scores in 131 cirrhotic patients without SHE and 48 cirrhotic
patients with SHE, compared with a reference group of 594 Dutch
persons (Jacobs39).

|
| View This
table |
table 3. SIP Scores of Cirrhotic Patients With and
Without SHE |
Separate analysis of total SIP score in patients with abnormal
psychometric tests, or with an abnormal EEG or with both abnormal
psychometric test(s) and abnormal EEG, showed equally impaired
total SIP scores: for psychometric tests: 14 (0.4-18.6); for EEG:
11.2 (8.4-14); and for both psychometric tests and EEG: 13.5
(6.9-20.2) versus 4.6 (3.7-5.5) (mean [95% confidence interval of
mean] for cirrhotic patients with normal test results [no
SHE]).
The results of the SIP scores were similar between the various
etiologies of chronic liver disease. Although patients with SHE
more often had cirrhosis of alcoholic etiology, patients with
alcoholic cirrhosis did not report more impairments on the
psychosocial, physical, or on the total SIP score, compared with
patients with nonalcoholic cirrhosis (data not shown).
Possible confounders in the analysis comparing patients with and
without SHE could be the severity of liver disease (Child-Pugh
score, presence of varices) and the etiology of cirrhosis
(including fatigue as often observed in viral disease and primary
biliary cirrhosis). Therefore, these variables were selected for
multivariate analysis to evaluate their impact on total SIP score.
This analysis showed that only presence of SHE and neither the
Child-Pugh score, presence of varices, nor the etiology of
cirrhosis significantly affects total SIP score (table 4).
|
View This
table
|
table 4. Effect of Presence of SHE, Child-Pugh Score,
Etiology (alcohol vs. non-alcohol), and Presence of Varices on
Total SIP Score |
Reliability testing of the SIP questionnaire in our patient
population using internal consistency measures showed that 10
subscales of the SIP fell below the recommended coefficient of 0.70
(table 3).
This finding suggests that the items of these SIP scales are not
homogeneous in the population of patients with cirrhosis, i.e., the
items of such a scale do not reliably represent an underlying
characteristic.43 The high internal consistency of the
total SIP score is at least partly attributable to the high number
of items. The reproducibility of the SIP questionnaire was high,
because we found a good correlation between the SIP results in a
3-month interval (table 5). Minor,
statistically not significant, differences of mean SIP scores were
found between the first and second completed SIP questionnaire,
indicating that, during the 3 months, patients had not
systematically changed with regard to the SIP questionnaire.
|
View This
table
|
table 5. SIP Scores of 38 Cirrhotic Patients at Baseline
and After 3 Months |
DISCUSSION
We performed a study to determine the influence of SHE on the
quality of life. Two psychometric tests with age-related normal
values (NCT-A and DST) and automated EEG analysis were selected to
be used as neuropsychological and neurophysiological screening
tests for SHE.15 We defined SHE as presence of at least
one abnormal psychometric test and/or abnormal slowing of the EEG
(at least grade 1 by spectral analysis). Using this definition, we
found a SHE prevalence of 27% in our outpatient cirrhotic
population, which is in agreement with the prevalence found in
studies using the same methods.13-15,17 We used the SIP
as a method for evaluating the influence of SHE on daily
functioning in cirrhotic patients, because this questionnaire
contains items that resemble the complaints seen in early stages of
hepatic encephalopathy. In addition, this questionnaire has been
used in a previous study in patients with SHE.10
In our study, we found a diminished level of functioning in
patients with SHE, as reflected by significantly more impairments
in all 12 categories of the SIP. Highest scores were found on the
categories of social interactions, alertness, emotional behavior,
mobility, sleep/rest, home management, and recreation and pastimes.
These are all items that are expected to be affected in cognitive
disorders. Although the severity and etiology of liver disease
could have influenced the total SIP scores, multivariate analysis
showed that only the presence of SHE independently accounts for the
total SIP score result.
Patients with hepatic encephalopathy grade 1 can complain about,
for example, sleep disturbances, impaired calculation, shortened
attention, mild personality changes, and muscular incoordination.44
Patients with SHE (in literature, considered as a preclinical stage
of hepatic encephalopathy) should therefore, although to a lesser
extent, have similar complaints in daily life. Our findings support
this assumption.
How reliable are our findings? First, our study was performed in
a large sample size (n = 179), which makes the results of the SIP
more adequate for statistical analysis.
Second, SHE was diagnosed using a combination of
neuropsychological and neurophysiological tests. We only used
validated psychometric tests with age-related normal values,
thereby abolishing the diagnostic bias caused by aging on
neuropsychological performance.15,17 The fact that
patients with abnormal psychometric tests as well as patients with
an abnormal EEG showed more impairments in daily life supports the
use of both neuropsychological and neurophysiological methods for
the diagnosis of SHE.
Third, we used a validated test to evaluate daily functioning,
with reference values for the Dutch population. In addition, we
found a good test-retest reliability of the SIP in our patient
population with cirrhosis.
Fourth, we tried to exclude confounding variables by applying
multivariate analysis. Age, etiology, and severity of cirrhosis did
not explain the difference in quality of life in cirrhotic patients
with and without SHE; this finding also excludes that symptoms such
as fatigue (a common symptom in viral disease and in primary
biliary cirrhosis), explain the observed difference.
Lastly, our findings are logical.
Should we treat patients with SHE because of the diminished
level of daily functioning found in this study? Up to now, no
intervention studies have been performed, in which functional
status is used as an outcome of treatment efficacy in SHE.
Treatment of SHE could be beneficial in patients with stable liver
disease and impaired performance at work or daily life. We
therefore strongly suggest the use of "health-related
quality-of-life questionnaires" in trials with treatment
specifically directed to SHE.
Footnotes
Abbreviations: SHE, subclinical hepatic encephalopathy;
SIP, Sickness Impact Profile; EEG, electroencephalogram; NCT-A,
Number Connection Test Part A; DST, Digit Symbol Test.
* Clinical manifest hepatic encephalopathy was assumed to
be present if at least two of the following abnormalities were
detected, or one abnormality in association with a flapping
tremor30: inverted sleep pattern, impaired calculation, disturbed
secondary memory, and slowness of speech. Impaired calculation was
assessed by asking the patient to subtract serial sevens from 100
and to repeat a series of six nonconsecutive numbers in the same
order (a normal individual can easily remember seven numbers
forward). Memory was tested by asking the patient to remember three
objects and to repeat these several minutes later, and by asking
the patient about past prime ministers, dates of wars, and events
that affect everyone.
Supported by the Netherlands Digestive Diseases
Foundation (grant WS 94-24)
Received August 4, 1997; accepted February 25,
1998.
Address reprint requests to: Prof. Dr. S.W. Schalm, Dept.
of Hepatogastroenterology & Internal Medicine II, Erasmus
University Hospital Rotterdam, P.O. Box 2040, 3000 CA Rotterdam,
The Netherlands. Fax: 31-10-436-5916.
REFERENCES
table Of Contents
Copyright © 1998 by the American Association for the
Study of Liver Diseases
|